Skip to main content

Happy FemTech Friday, 

The Global Women’s Health App Market Size is Expected to Reach USD 15.6 Billion by 2033, According to a research report published by Spherical Insights. Based on the type, the global women’s health app market is divided into fitness & nutrition, menstrual health, pregnancy tracking and postpartum care, menopause, disease management, and others.

Market Segmentation: – Classified into type, modality, and age group.

  • Menstrual health segment expected to dominate, driven by awareness, disposable incomes, and collaborations.
  • Smartphone segment holds the largest share due to accessibility and user-friendly interfaces, especially for menstrual tracking and fertility management.
  • The 25 to 34 years age group leads in market share, driven by emphasis on reproductive health, tech-savviness, and preference for digital solutions.

Regional Segment Analysis:

  • North America (U.S., Canada, Mexico) 
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and the Rest of South America) 
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

Key Companies :

Clue, Fitbit Inc. (Google LLC), Flo Health Inc., Glow Inc., Maven Clinic Co., Natural Cycles USA Corp., Ovia Health, Mithra Pharmaceuticals Group Limited, Mayne Pharma, Lynparza, HelloBaby, Inc., Apple Inc. and Others.

My Big Takeaways :

🚀 North America is anticipated to hold the largest share of the global women’s health app market over the predicted forecast period.

🚀 Europe is expected to grow the fastest during the forecast period.

Interested in getting the scoop on the Indian market? Drop me an email. We’re currently building the first-ever series of FemTech reports on the Indian market.

Your Friends, 


What’s trending this week in women’s health :

💰Funding In India: FemTech, Wellness, and Fitness

EzeRx, a developer of portable non-invasive devices to detect anaemia which has Sun Pharma as one of its largest stakeholder is in talks with two venture capital firms to raise fresh equity funding.

🌎💸  Global Funding

  • The US menopause start-up Midi Health has secured US$60m in funding, bringing the company’s total funding raised to date to US$100m. The funding round was led by Emerson Collective, with support from additional investors, including GV (Google Ventures), Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel Group, Gingerbread Capital, Able Partners, G9 and Operator Collective.
  • The US women’s health start-up Pelvital has raised US$2.32m in funding to address “unanswered” pelvic health issues.Minnesota-based Pelvital aims to restore pelvic health with its first product Flyte, an FDA-cleared intravaginal treatment for stress urinary incontinence (SUI) and weakened pelvic floor muscles.
  • Endeavor BioMedicines, Inc., a San Diego, CA-based clinical-stage biotechnology company, closed a $132.5m Series C financing, including the conversion of a $5m convertible instrument.
  • RevOpsis Therapeutics, a San Carlos, CA-based biopharmaceutical company spearheading innovation in ophthalmic therapies, closed its first seed funding round, raising $16.5m.
  • AtaCor Medical, a San Clemente, CA-based medical device company, raised $28M in Series C funding.The round was led by Arboretum Ventures and included existing investors Longview Ventures, Hatteras Venture Partners, Catalyst Health Ventures, and BayMed Venture Partners.
  • Handl Health, a Los Angeles, CA-based provider of an AI platform built to help benefits consultants design and deliver health benefits, raised $2.5M in Seed funding.


  • Researchers at the Indian Institute of Science (IISc), Bengaluru have designed a synthetic compound which is an antigen that can latch onto a protein in blood. It then hitch hikes a ride to the lymph node, where it can boost the production of antibodies against cancer cells. This leads cancer cells to reduce the production of antibodies and eliminate them.
  • CAR-T cell therapy in oncology is gaining momentum not only in India but globally. Oncologists in the country are now seen to advice CAR-T therapy which is approved for specific types of blood cancers, including acute lymphoblastic leukemia (ALL), large B-cell lymphoma and multiple myeloma.Oncologists note that the therapy’s success is based on the clinical trials, which has indicated remissions in patients who have exhausted other treatment options. 
  • Experts have raised concerns over the “pervasive” economic and health challenges women in the US are facing, after a damning report exposed significant financial stress. A national survey of women over 25 has found that American women face significant economic stress, with half of women reporting feeling “uncertain” or “worried” when thinking about how to pay for healthcare later in life and low-income and rural women reporting challenges to staying healthy today.
  • Head and neck cancers account for 25 percent of all solid organ cancers in India. These are generally more common in men than women. Such cancers can form in the oral cavity, throat, voice box, nasal cavity and salivary glands.
  • The main causes of poor health impacting quality of life are low back pain, depressive disorders and headaches, according to a new global research published in The Lancet journal. The study analysed healthy life expectancy during the first two years of the COVID-19 pandemic, and found that even though people around the world are living longer, “they aren’t spending all those years in good health.”
  • GSK plc announced the US Food and Drug Administration (FDA) accepted the supplemental Biologics License Application (sBLA) for Jemperli (dostarlimab) in combination with standard-of-care chemotherapy (carboplatin and paclitaxel) to expand treatment to all adult patients with primary advanced or recurrent endometrial cancer. This would include patients with mismatch repair proficient (MMRp)/microsatellite stable (MSS) tumours.
  • The WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets.
  • Technology is now seen to optimise liver disease care with AI-powered algorithms, imaging analysis & predictive modelling, according to hepatologists in the country.Liver disease is a growing concern in India, affecting millions. These can be inherited or caused by excessive alcohol consumption and obesity. Chronic liver disease progresses through four stages: hepatitis, fibrosis, cirrhosis, and finally, liver failure.
  • An NIHR-funded study has found that the use of antipsychotic medication to treat symptoms of dementia is associated with higher risks of a wide range of serious health outcomes. The study found that the risks for patients are highest soon after they start taking the drugs. This suggests that more caution is needed around prescribing.
  • The Canadian insurer Medavie Blue Cross (MBC) has partnered with the virtual health platform sanoLiving to support women on their menopause journey. Currently, more than 10 million Canadian women are navigating menopause, often with little support and misinformation about treatments.
  • Cleveland Clinic has launched its new Women’s Comprehensive Health and Research Center, an initiative dedicated to helping women during midlife. The center, which will focus on access, connectivity, education and research and innovation, aims to empower women to navigate their health journey with confidence and clarity.

🤝 Our Ecosystem News:

  • PeeSafe has released another edition of #PeeRoomConversations and covered the aspect of dealing with loneliness and being single in your 30s.
  • Mind&Mom joined the South Korean landscape and has officially expanded the South Korean ecosystem.
  • Dr. Nikita Dound and Karishma Chava of Sassiest released the 3rd episode of the Sass it up podcast, where they covered the topic of pleasure toys.
  • Rithish Kumar, Co-founder of PeeSafe was interviewed by Marketing Mind where he covered topics of hygiene and wellness.

🌐 Global Companies:

  • A Singapore-based fertility centre, Virtus Fertility Centre Singapore (VFCS)  is to set up a grant to support couples struggling to conceive. The company announced that it would set up a grant to support aspiring parents on their IVF journey.  The initial grant is set for at $50,000 SGD and, depending on the take-up rate over the next 12 fiscal months, VFCS plans to increase the pool to benefit more couples in the subsequent years.
  • The Irish women’s health start-up Riley has launched an ad campaign on the London Underground to “take the fear out of periods”. Riley, an eco-friendly period product subscription service, aims to take action against period poverty and democratise access to period products.
  • The US diagnostics company Proov has announced that an equity share of the company has been purchased by Grammy award-winning singer-songwriter and actor Ashanti and her fiancé, entertainment icon Nelly.

🇮🇳 Government News

  • The Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homoeopathy (Ayush) manufacturing industry in the country has registered around six times growth in seven years from the year 2014-15, since the upgradation of the Department of Ayush to the Ministry.
  • The Indian Institute of Technology (IIT), Roorkee and Gurugram-based UnivLabs Technologies Private Limited have signed a Technology Transfer Agreement and a Memorandum of Agreement (MoA) for translating research findings into real-world applications.

Quick Reads (Science)

Do you really need 10,000 steps a day? Here’s what science says – Read here 

🎉Have news to share? Publish a press release on FemTech India to reach industry-leading executives, investors, and passionate individuals.

See you next Friday Friends

[Sign up here to never miss on the latest updates.]

Today’s newsletter is brought to you by Navneet Kaur and Jayant Pal Singh